The large-scale clinical study identified the long-term rebleeding rates and predictive rebleeding factors (IMAGE)
Caption
The overall cumulative rebleeding rate in the five years after capsule endoscopy (CE) was as high as 41.7%. Overt obscure gastrointestinal bleeding (OGIB), anticoagulants, positive balloon-assisted enteroscopy (BAE) after CE, iron supplements without therapeutic intervention, and liver cirrhosis were found to be independent predictors of rebleeding in patients with OGIB. Each predictor’s hazard ratio (HR) was identified.
Credit
Koji Otani, OMU
Usage Restrictions
News organizations may use or redistribute this image, with proper attribution, as part of news coverage of this paper only.
License
Original content